Sun-Ranbaxy deal: CCI public scrutiny deadline ends today
The USD 4-billion deal would create the fifth largest specialty generics company in the world and the largest pharmaceutical company in India.
Sep 24, 2014, 17:10 PM IST
CCI expands probe into Sun-Ranbaxy deal; seeks public scrutiny
This is probably the first instance where the CCI has ordered a public scrutiny of a proposed merger and acquisition (M&A) deal to ensure compliance to fair trade regulations.
Aug 28, 2014, 11:04 AM IST
Sun-Ranbaxy deal pushes domestic H1, M&As jump 22%
Domestic M&As stood at USD 10.1 billion, up 295.9 per cent compared to the first half of 2013.
Jul 03, 2014, 17:39 PM IST
